Research note • Information available October 1, 2026, 3:17 p.m. EDT
Did Trump and Pelosi spot something in Vistra that other investors missed? The disclosures offer a more complicated story: Paul Pelosi bought call options and later exercised them; Trump’s reports contain both purchases and sales. Neither provides an exact all-in entry price. [1][2][3][4]
Our view is that Vistra owns attractive power assets, but around $140 we would wait for a better entry or stronger cash-flow evidence. The number carrying that judgment is an estimated 4.3%–6.0% cash yield after identified growth spending and preferred distributions, with a midpoint of 5.2%. The company’s more prominent before-growth measure produces a 9.2% midpoint yield. That difference is where the investment debate belongs. [5][6][7]
A reported political trade is an invitation to investigate. Our investment case rests on who pays for electricity, what Vistra must spend to supply it, and how much remains for common shareholders.
Pelosi’s $50 was the strike; Trump’s entry prices are undisclosed
Paul Pelosi’s original purchase was on January 14, 2025: 50 Vistra call contracts, with a $50 strike and January 16, 2026 expiration. Nancy Pelosi’s House report marked the position as spouse-owned and placed the purchase in the $500,001–$1 million transaction band. On January 16, 2026, a subsequent report recorded exercise into 5,000 shares. [1][2]
A call buyer pays twice if the option is exercised: first the premium for the right to buy, then the strike price for the shares. Here, exercise required 5,000 × $50, or $250,000. Assuming the original disclosed transaction band represents the aggregate premium paid, premium plus exercise implies an all-in cost of approximately $150–$250 per underlying share, excluding fees. The exact premium remains private. [1][2]
Trump’s disclosures are less specific about the security. The original rows generally identify “Vistra Corp”; a secondary transaction index classifies the entries as VST equity. The filings give transaction-dollar bands, while leaving execution prices, quantities and the precise beneficial account unspecified. The selected original entries below show activity in both directions. [8][3][4][9]
Exhibit 1. Pelosi bought calls; Trump’s reports show buying and selling
| Investor / date | Reported transaction | Disclosed amount | Sources |
|---|
| Paul Pelosi · Jan. 14, 2025 | 50 calls; $50 strike; Jan. 16, 2026 expiry | $500,001–$1,000,000 | [1] |
| Paul Pelosi · Jan. 16, 2026 | Exercise into 5,000 shares | $100,001–$250,000 | [2] |
| Trump report · March 2, 2026 | Vistra purchase | $15,001–$50,000 | [8] |
| Trump report · March 26, 2026 | Vistra sale | $1,001–$15,000 | [8] |
| Trump report · May 11, 2026 | Vistra purchase | $50,001–$100,000 | [3] |
| Trump report · May 18, 2026 | Vistra sale | $100,001–$250,000 | [3] |
| Trump report · May 22, 2026 | Vistra purchase | $50,001–$100,000 | [3] |
| Trump report · July 20, 2026 | Vistra purchase | $100,001–$250,000 | [4] |
The disclosures reveal instruments, dates and transaction bands; precise investment cost requires information beyond these filings.
Sources: House periodic transaction reports and Trump OGE reports. Selected entries; the Trump list is incomplete. [1][2][8][3][4]
The July purchase was reported in September. That lag matters: a disclosure headline can describe a decision made weeks earlier, after which the investor may have traded again. We cannot reconstruct Trump’s current Vistra position or realized returns from these transaction bands. [4]
We give the political trades essentially no valuation weight
There is no documented Vistra-specific investment explanation from Paul Pelosi or Trump’s portfolio managers in the reviewed disclosures and statements. A Pelosi spokesperson said Nancy had “no prior knowledge or subsequent involvement” in the transactions. The White House described Trump’s portfolio as independently managed by financial institutions through discretionary, computer-based portfolios replicating recognized indexes. Both are attributed accounts of decision-making. [1][2][10][11]
The White House’s explanation makes routine portfolio allocation a credible explanation for Trump-reported activity. It gives us little reason to interpret each purchase as a personal judgment about future electricity prices. Paul Pelosi’s option position expresses a more identifiable exposure, but its existence tells us little about the valuation assumptions behind it.
The plausible public thesis is straightforward: electricity demand is rising, and existing reliable generation can become more valuable. Vistra’s agreement with Meta gives that thesis a named customer and a long contract. Announced in January 2026, however, it came nearly a year after Paul Pelosi’s original option purchase. We would not retroactively assign that announcement as his reason for buying. [12][1]
That leaves the question investors can actually answer: are Vistra’s assets likely to earn enough to justify today’s price?
Vistra can collect scarcity profits, but hedges set the pace
Vistra combines competitive electricity generation with retail energy sales. A generator earns from selling electricity and, in some markets, from being available when the system needs capacity. Stronger demand can lift those revenues without requiring an existing plant to be rebuilt. Retail supply provides another earnings stream and an offset to some wholesale exposure, although weather, outages and commodity costs still matter. These economics differ from a regulated utility’s allowed return on invested capital. [13]
The asset base is substantial: approximately 43.8 GW of generation capacity before Cogentrix and about five million retail customers. At year-end 2025, natural gas represented roughly 27 GW, compared with 6.45 GW of nuclear capacity. We like the nuclear assets, but treating Vistra solely as an AI nuclear stock conceals how much of its economics comes from the broader fleet and retail business. [13][6]
The earnings are already growing. Management’s 2026 ongoing adjusted EBITDA guidance is $6.8–$7.6 billion. Its $7.2 billion midpoint is about 22% above the $5.91 billion earned in 2025. That is meaningful progress, although acquisitions and their timing affect the comparison. [14][15]
The timing of further upside depends on contracts already in place. As of early August, Vistra had hedged approximately 94% of expected 2027 generation and 72% for 2028. Selling ahead improves earnings visibility, while limiting how quickly higher spot prices reach reported results. Electricity demand can accelerate before Vistra’s realized margins do. [14]
Scarcity also invites political intervention. The cited PJM capacity auction cleared at its approved $325 per MW-day cap for the 2028/29 delivery year. Existing generation benefits from a tight system, but the system’s customers—and ultimately regulators—have a say in how much scarcity rent producers collect. [16]
Meta validates the assets; incremental profit depends on the terms
Meta’s 20-year agreements cover 2,176 MW of existing nuclear generation at Perry and Davis-Besse, plus 433 MW of planned uprates across those plants and Beaver Valley. Purchases begin in late 2026, with additional capacity phased in through 2034. Only about 16.6% of the contracted capacity is new output, calculated by dividing the uprates by the total 2,609 MW. [12]
The distinction matters economically. Existing output was already being sold. Its incremental value comes from better prices, longer commitments or more favorable risk allocation. Uprates add electricity to sell, but require investment first. Adding all of the contract’s gross consideration to Vistra’s earnings would count revenue the plants already generated.
Chief executive Jim Burke explained the useful part of the bargain: Meta’s commitment provides “the certainty needed to invest in these plants and communities and bring new nuclear generation online for the grid.” The customer obtains long-term supply; Vistra gains the commercial support to extend and expand valuable assets. [12]
Our fully ramped sensitivity puts incremental annual operating contribution at roughly $0.15–$0.63 billion, before growth capital, financing, tax and tax-credit interactions. At an assumed 90% capacity factor, the existing contracted output produces about 17.2 TWh annually and the uprates 3.4 TWh. Applying an assumed $5–$25/MWh premium to existing output and $20–$60/MWh contribution to new output yields that range. These are our price and margin assumptions; the release specifies capacity and timing but leaves pricing private. [12]
We take the agreement seriously because it converts a broad demand narrative into a contractual relationship. We remain price-sensitive because delivery stretches over years and the incremental return depends on capital costs as well as electricity prices.
Vistra is also helping finance the ecosystem it hopes to supply. Its initial commitment to Helix Digital Infrastructure is up to $1 billion, alongside investors including KKR, NVIDIA and the Kuwait Investment Authority. Being a preferred power provider creates an opportunity; supplying capital creates an obligation to earn a return. [14][17]
Growth spending takes the cash yield from 9.2% to about 5.2%
The cash bridge is the strongest reason for our restraint. Management’s 2026 ongoing adjusted free-cash-flow-before-growth guidance is $3.925–$4.725 billion. At the midpoint, $4.325 billion divided by approximately $47 billion of common equity value gives a 9.2% yield. The equity value uses the observed price around $140 and the latest located outstanding share count. [14][5][7]
But shareholders also fund asset closure, development and senior distributions. Incorporating the consolidated Asset Closure adjustment, subtracting approximately $1.525 billion of total capex above company-adjusted capex, and allowing approximately $192 million for annualized preferred distributions leaves $2.04–$2.84 billion, with a $2.44 billion midpoint. That is the 4.3%–6.0% yield range guiding our judgment. [5][6]
Exhibit 2. The cash yield falls from 9.2% to 5.2% after identified deductions
Identified spending and senior distributions absorb approximately $1.9 billion of the ongoing before-growth midpoint.
[5][6][7]View data — original input
Original input data for Exhibit 2. The cash yield falls from 9.2% to 5.2% after identified deductions; chart filters and transformations do not change this table.| step | start | end | label | type | order |
|---|
| Before growth | 0 | 4.325 | $4.33bn | Cash subtotal | 1 |
| Asset closure | 4.16 | 4.325 | −$0.17bn | Deduction | 2 |
| Additional capex | 2.635 | 4.16 | −$1.53bn | Deduction | 3 |
| Preferred payouts | 2.443 | 2.635 | −$0.19bn | Deduction | 4 |
| After deductions | 0 | 2.443 | $2.44bn | Cash subtotal | 5 |
Identified spending and senior distributions absorb approximately $1.9 billion of the ongoing before-growth midpoint.
Sources: Vistra Q2 presentation and 10-Q; our arithmetic. Note: 2026 guidance midpoints, approximately $47.02 billion common equity value. The capex deduction equals $3.025 billion total less $1.500 billion adjusted capex; individual growth rows are not deducted again. Preferred distributions are annualized. The resulting adjusted cash estimate precedes acquisition consideration and other unmodeled adjustments. [5][6][7]
The reported cash statement provides a useful grounding. In the first half of 2026, operating cash flow was $2.222 billion, while capital expenditures including nuclear fuel and long-term service agreement prepayments were $1.572 billion. The difference was $650 million before acquisitions, financing and distributions. Seasonality makes a simple doubling unhelpful, but the figures show the demands on actual cash alongside adjusted earnings growth. [5]
Our skepticism is about the price paid for that cash stream. A roughly 5.2% midpoint yield leaves us wanting either more confidence in the investments being made today or a larger discount in the shares.
A central value around $140–$145 leaves little room for disappointment
Our valuation starts with approximately $47.0 billion of common equity, adds $18.6 billion of net debt and $2.48 billion of preferred liquidation claims, and arrives at enterprise value of about $68.1 billion. Against the 2026 consolidated adjusted EBITDA midpoint of $7.12 billion, that is approximately 9.6 times. The inputs combine the recent price with June and August capital snapshots, so this is an indicative valuation. [5][6][7]
For the next earnings step, Cogentrix matters. The announced consideration includes approximately $2.3 billion cash, five million new shares and $1.5 billion assumed debt. The advertised $4 billion net purchase price deducts $700 million of expected tax-benefit present value. Dividing that advertised price by management’s stated 7.25-times acquisition multiple implies approximately $552 million of expected 2027 EBITDA. [18]
We add that contribution to the center of management’s $7.4–$7.8 billion 2027 ongoing EBITDA opportunity, which excludes Cogentrix and Meta. The resulting $8.15 billion provides our central earnings assumption. Adding the cash consideration, assumed debt and newly issued shares to enterprise value produces a pro-forma multiple of approximately 8.9 times at $140.10. [6][18][7]
Exhibit 3. Our central valuation is close to the share price
The central case sits near the observed share price; meaningful upside requires stronger earnings, a higher multiple and lower senior claims.
Sources: Vistra disclosures; analyst assumptions. Note: value equals EBITDA times the assumed multiple, less net debt and preferred claims, divided by 340.64 million pro-forma shares. Claims are $25.5 billion, $24.89 billion and $23.5 billion across the cases. The central case uses ongoing EBITDA; carrying forward the 2026 Asset Closure drag lowers its value by about $2 per share. No probability weights are assigned. [5][6][18]
These assumptions give us a central value of approximately $140–$145, with bear and bull cases near $90 and $200. We favor an entry around $110–$115, provided the operating thesis remains intact: roughly a 20% discount to central value. That is our chosen margin of safety for the business and capital-allocation risks.
The September financing also needs careful treatment. Vistra issued $1.5 billion of junior subordinated notes, with proceeds available for general purposes including a later preferred redemption. Cash proceeds and any replacement of preferred capital belong in the same reconciliation as the new debt. We therefore retain the disclosed balance-sheet anchor rather than mechanically increase net debt by the issuance amount. [19]
Better contracted returns could overturn our caution
The strongest case against us is that we undervalue the durability of the fleet. Long contracts could make earnings more dependable, future agreements could improve margins, and management’s 2027 opportunity already excludes Meta and Cogentrix. The roughly $200 bull case deserves substantial weight if earnings growth, debt reduction and investor confidence reinforce one another. [6][12]
We would become more constructive at the current price with credible consolidated EBITDA approaching our $8.7 billion bull assumption, accompanied by stronger cash after growth spending. Disclosed power-contract pricing, capital commitments and delivery schedules showing attractive incremental returns would also help. At a lower share price, less improvement would be required.
The opposite developments would weaken our view: contracting delays, higher growth costs, weaker realized margins or rising leverage. Moss Landing adds a separate liability concern. The June filing estimated approximately $175 million of remediation costs under the EPA agreement, including a second-quarter increase; other eventual liabilities remain a further exposure. [5]
Trade confirmations could settle the politicians’ actual entry prices. Investment instructions or direct explanations could clarify motive. For our decision, the more consequential disclosure is what Vistra earns on the capital it is committing now. The next persuasive buy signal would be a better price—or better cash economics.
Comments